CAMP Q2 2017 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$126M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$88M-3.4% YoY

Gross Profit

$37M42.5% margin

Operating Income

-$1M-1.5% margin

Net Income

-$3M-3.0% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+2.3%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$427M

Total Liabilities

$253M

Stockholders' Equity

$174M

Cash & Equivalents

$109M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$88M	$91M	-3.4%
Gross Profit	$37M	$35M	+7.5%
Operating Income	-$1M	-$2M	+34.8%
Net Income	-$3M	-$3M	+0.2%

Geographic Segments

United States

$64M73%

Europe, Middle East and Africa

$11M13%

South America

$4M4%

Canada

$3M4%

All other

$3M4%

Asia and Pacific Rim

$3M3%